These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31543976)

  • 1. Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.
    Cardona S; Tsegka K; Pasquel FJ; Fayfman M; Peng L; Jacobs S; Vellanki P; Halkos M; Guyton RA; Thourani VH; Galindo RJ; Umpierrez G
    BMJ Open Diabetes Res Care; 2019; 7(1):e000703. PubMed ID: 31543976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: A randomized controlled trial.
    Cardona S; Tsegka K; Pasquel FJ; Jacobs S; Halkos M; Keeling WB; Davis GM; Fayfman M; Albury B; Urrutia MA; Galindo RJ; Migdal AL; Macheers S; Guyton RA; Vellanki P; Peng L; Umpierrez GE
    Diabetes Obes Metab; 2021 Feb; 23(2):480-488. PubMed ID: 33140566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study.
    Fayfman M; Davis G; Duggan EW; Urrutia M; Chachkhiani D; Schindler J; Pasquel FJ; Galindo RJ; Vellanki P; Reyes-Umpierrez D; Wang H; Umpierrez GE
    J Diabetes Complications; 2018 Dec; 32(12):1091-1096. PubMed ID: 30253968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes.
    Underland LJ; Ilkowitz JT; Katikaneni R; Dowd A; Heptulla RA
    J Diabetes Sci Technol; 2017 May; 11(3):602-610. PubMed ID: 28349708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.
    Pasquel FJ; Gianchandani R; Rubin DJ; Dungan KM; Anzola I; Gomez PC; Peng L; Hodish I; Bodnar T; Wesorick D; Balakrishnan V; Osei K; Umpierrez GE
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):125-133. PubMed ID: 27964837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy.
    Cardona S; Pasquel FJ; Fayfman M; Peng L; Jacobs S; Vellanki P; Weaver J; Halkos M; Guyton RA; Thourani VH; Umpierrez GE
    J Diabetes Complications; 2017 Apr; 31(4):742-747. PubMed ID: 28161384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial.
    Gracia-Ramos AE; Cruz-Dominguez MDP; Madrigal-Santillán EO; Rojas-Martínez R; Morales-González JA; Morales-González Á; Hernández-Espinoza M; Vargas-Peñafiel J; Tapia-González MLÁ
    J Diabetes Complications; 2024 May; 38(5):108742. PubMed ID: 38581842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial).
    Masuda D; Kobayashi T; Sairyou M; Hanada H; Ohama T; Koseki M; Nishida M; Maeda N; Kihara S; Minami T; Yanagi K; Sakata Y; Yamashita S
    J Atheroscler Thromb; 2018 Jun; 25(6):512-520. PubMed ID: 29199201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial.
    Umpierrez G; Cardona S; Pasquel F; Jacobs S; Peng L; Unigwe M; Newton CA; Smiley-Byrd D; Vellanki P; Halkos M; Puskas JD; Guyton RA; Thourani VH
    Diabetes Care; 2015 Sep; 38(9):1665-72. PubMed ID: 26180108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
    Garg SK; Moser EG; Bode BW; Klaff LJ; Hiatt WR; Beatson C; Snell-Bergeon JK
    Endocr Pract; 2013; 19(1):19-28. PubMed ID: 23186950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes: A randomized, placebo-controlled study.
    Farngren J; Persson M; Ahrén B
    Diabetes Obes Metab; 2018 Aug; 20(8):1911-1920. PubMed ID: 29645341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining the G-protein-coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12-week trial.
    Peng XV; Marcinak JF; Raanan MG; Cao C
    Diabetes Obes Metab; 2017 Aug; 19(8):1127-1134. PubMed ID: 28239939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin as an adjunct to insulin for glycemic control in patients with type 2 diabetes after CABG surgery: a randomized double blind clinical trial.
    Baradari AG; Emami Zeydi A; Aarabi M; Ghafari R
    Pak J Biol Sci; 2011 Dec; 14(23):1047-54. PubMed ID: 22590838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and Oxidative Stress in Cardiac Surgery Patients Treated to Intensive Versus Conservative Glucose Targets.
    Reyes-Umpierrez D; Davis G; Cardona S; Pasquel FJ; Peng L; Jacobs S; Vellanki P; Fayfman M; Haw S; Halkos M; Guyton RA; Thourani VH; Umpierrez GE
    J Clin Endocrinol Metab; 2017 Jan; 102(1):309-315. PubMed ID: 27841946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do nondiabetic patients undergoing coronary artery bypass grafting surgery require intraoperative management of hyperglycemia?
    Azarfarin R; Sheikhzadeh D; Mirinazhad M; Bilehjani E; Alizadehasl A
    Acta Anaesthesiol Taiwan; 2011 Jun; 49(2):41-5. PubMed ID: 21729808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice changes in glycemic management and outcomes in coronary artery bypass surgery patients.
    Pennell L; Smith-Snyder CM; Hudson LR; Hamar GB; Westerfield J
    J Cardiovasc Nurs; 2005; 20(1):26-34. PubMed ID: 15632810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.
    Ahrén B; Masmiquel L; Kumar H; Sargin M; Karsbøl JD; Jacobsen SH; Chow F
    Lancet Diabetes Endocrinol; 2017 May; 5(5):341-354. PubMed ID: 28385659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous GLP-1 (7-36) amide for prevention of hyperglycemia during cardiac surgery: a randomized, double-blind, placebo-controlled study.
    Kohl BA; Hammond MS; Cucchiara AJ; Ochroch EA
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):618-25. PubMed ID: 24144627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial.
    El Messaoudi S; Nederlof R; Zuurbier CJ; van Swieten HA; Pickkers P; Noyez L; Dieker HJ; Coenen MJ; Donders AR; Vos A; Rongen GA; Riksen NP
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):615-23. PubMed ID: 26179504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.